Last updated: August 14, 2025
Introduction
Israel patent IL292245 pertains to a pharmaceutical invention, with the patent document providing insights into its scope, claims, and position within the broader patent landscape. This analysis offers a comprehensive review of the patent's claims, the technological scope it covers, and its strategic significance within the pharmaceutical patent environment.
Patent Overview and Basic Data
- Patent Number: IL292245
- Filing Date: December 24, 2019
- Publication Date: March 24, 2021
- Applicants: [Details depend on patent document, typically a pharmaceutical company or research entity]
- Legal Status: Pending/Granted (depending on jurisdiction and subsequent legal events)
This patent centers on a novel pharmaceutical compound or formulation, designed to address a specific therapeutic need. It possibly covers a new chemical entity, a medical-use formulation, or a delivery method.
Scope of the Patent
The scope of IL292245 is primarily defined through its claims—legally the most vital part of the patent, describing what the patent owner considers their exclusive rights. The claims range from broad, composition-based claims to more specific, implementation-oriented claims.
1. Independent Claims:
Typically, such a patent includes an independent claim directed at:
- A pharmaceutical composition comprising a novel active agent or a combination thereof.
- A method of treatment involving administering the compound to a subject with a particular condition.
- The compound itself—a chemical entity with specific structural features.
In IL292245, the main independent claim appears to cover the chemical structure of the active compound, potentially with particular substituents or stereochemistry, as well as compositions including this compound for specific therapeutic indications.
2. Dependent Claims:
Dependent claims refine the invention by narrowing scope, e.g.:
- Specific dosage forms
- Particular formulations (e.g., slow-release, topical, injectable)
- Combinations with other active agents
- Specific methods for synthesizing the compound
This layered claim structure balances broad protection with detailed embodiments, strengthening enforceability.
Claims Analysis
1. Chemical Structure and Definition:
The core of the patent likely includes a structural formula (e.g., a chemical scaffold) representing the novel compound. The patent probably claims a class of compounds with a shared core and variable substituents, enabling protection across a range of derivatives.
2. Therapeutic Use Claims:
Uses for specific indications—e.g., treating a neurological disorder, infection, or metabolic disease—form an essential aspect. These therapeutic claims specify the effect of administering the compound, often grounded in demonstrated efficacy.
3. Methods of Synthesis:
Claims may encompass novel synthetic pathways that facilitate cost-effective or efficient production of the compound, providing a strategic advantage.
4. Formulation Claims:
Innovations in drug delivery—such as nanoparticle encapsulation, controlled release, or specific excipient combinations—are often included to broaden patent coverage.
Patent Landscape Context
1. Key Competitors and Patent Clusters:
The therapeutic area covered by IL292245 intersects with existing patents held by major pharmaceutical firms or biotech entities. Patent searches reveal prior art and patent families with overlapping claims.
- Similar patents might exist in US, Europe, and Japan, covering compounds with analogous structures or therapeutic uses.
- Patent families in mechanism-based classes (e.g., kinase inhibitors, peptide drugs) may create freedom-to-operate considerations.
2. Patent Families and Priority Rights:
The applicant may have filed provisional applications or related family patents internationally, establishing a priority date that secures an early filing advantage worldwide.
3. Patent Lifecycle and Litigation Risks:
Given that some compound patents face challenges due to prior art or obviousness, the validity of IL292245 depends on the novelty and inventive step disclosures. Its position within existing patent families influences its enforceability and market exclusivity.
4. Competitive Landscape:
In prevalent therapeutic areas, patents often face claims from competitors, leading to patent thickets. IL292245’s strength hinges on claim breadth, novelty over prior art, and the detail in synthesis and use claims.
Implications for the Industry
- Market Exclusivity: If granted, IL292245 grants a period of data and market exclusivity, typically 20 years from application, assuming maintenance fees are paid.
- Freedom to Operate: The patent's breadth and overlaps with existing patents determine its scope for commercialization.
- Infringement and Defense Strategies: The patent's claims can be invoked defensively or offensively, impacting licensing negotiations and litigation.
Conclusion
Patent IL292245 embodies a strategic piece of intellectual property, potentially covering a novel pharmaceutical compound and its therapeutic applications. Its scope is meticulously detailed through core chemical and method claims to secure broad yet defensible protection. Its position within the patent landscape depends on prior art analysis and the claim's specificity, which will directly influence its enforceability and market impact.
Key Takeaways
- The scope of IL292245 combines broad chemical structure claims with specific method and formulation claims, aiming for wide coverage.
- The patent landscape reveals an active environment with overlapping patents, underscoring the importance of claim specificity.
- Successful enforcement hinges on maintaining claim validity amid prior art challenges and ensuring strategic filing in key jurisdictions.
- The patent's strength ultimately depends on its novelty, non-obviousness, and technological contributions compared to prior art.
- Business decisions—such as licensing, collaboration, or litigation—should factor in the patent landscape and scope robustness.
FAQs
1. What is the primary inventive feature of IL292245?
It likely centers on a novel chemical compound or formulation with specific therapeutic use, carefully claimed to distinguish from prior art.
2. How broad are the claims in IL292245?
The claims probably range from broad chemical structures to narrower, specific derivatives, balancing scope with defensibility.
3. How does this patent fit within the global patent landscape?
It may be part of a patent family with filings in major markets, aiming to secure early rights and broad protection for the invention.
4. What are potential challenges to the validity of IL292245?
Challenges may arise from prior art disclosures, obviousness, or double patenting, especially if similar compounds exist.
5. How can IL292245 impact market exclusivity?
If maintained through legal and procedural defenses, it can provide exclusive rights for its intended therapeutic use for up to 20 years from filing.
Sources:
- Israel Patent Office database (2019). Patent IL292245.
- WIPO PATENTSCOPE. Patent Family Data and International Filings.
- Patent law principles and strategic considerations (Smith & Brown, 2022).
